Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742235 · ClinicalTrials.gov registry record · NA
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
A NA study of Healthy Subjects and Vitamin D Deficiency, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT00742235: Completed NA study of Healthy Subjects and Vitamin D Deficiency, sponsored by Massachusetts General Hospital.
NCT00742235 is a NA study of Healthy Subjects and Vitamin D Deficiency that has completed, run by Massachusetts General Hospital. The registered enrollment target is 99 participants, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00742235, a NA study of Healthy Subjects and Vitamin D Deficiency, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitamin D deficiency (low levels of vitamin D in the blood) is a common problem. A recently discovered protein, called hCAP18, likely plays an important role in the immune system and may depend on adequate levels of vitamin D. It is not known what levels of vitamin D are needed to allow the body to make this protein. Nor is it known if giving vitamin D to people who are found to be deficient will help boost levels of hCAP18. This study aims to clarify the relationship between vitamin D levels and hCAP18.
Conditions Studied
Interventions
- DRUG ergocalciferol
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2007-07 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00742235 record still lists
NCT00742235 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (22% lower).
The record links to 2 conditions, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which ergocalciferol is the first listed.
NCT00742235 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00742235 about?
NCT00742235 is a clinical study titled "hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects". Vitamin D deficiency (low levels of vitamin D in the blood) is a common problem. A recently discovered protein, called hCAP18, likely plays an important role in the immune system and may depend on adequate levels of vitamin D. It is not known what levels of vitamin D are needed to allow the body to ...
What is the current status of trial NCT00742235?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2007-07. Estimated completion is 2012-01.
What conditions does trial NCT00742235 study?
This clinical trial studies the following conditions: Healthy Subjects, Vitamin D Deficiency.
What interventions are being tested in trial NCT00742235?
The interventions under investigation include: ergocalciferol (DRUG).
Who is sponsoring clinical trial NCT00742235?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00742235 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00742235's enrollment target sits among peer trials
99 13th of 69 higher than 57 of 69 other Healthy Subjects trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
RECRUITING · NA
-
Echography Study_Anthropometric Measurements
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
RECRUITING · NA
-
In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia